𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Switching to a new TNF-α inhibitor may help spondyloarthropathy patients

Book ID
120846597
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2007
Weight
133 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A case of infliximab-induced lupus in a
A case of infliximab-induced lupus in a patient with ankylosing spondylitis: is it safe switch to another anti-TNF-α agent?
✍ Santiago, Tânia; Santiago, Mariana Galante; Rovisco, João; Duarte, Cátia; Malcat 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 117 KB

Anti-TNF-α therapies are the latest class of medications found to be associated with drug-induced lupus, a distinctive entity known as anti-TNF-α-induced lupus (ATIL) (Williams et al., Rheumatology (Oxford) 48:716-20, 2009; De Rycke et al., Lupus 14:931-7, 2005; De Bandt et al., Clin Rheumatol 22:56